3D Cell Culture Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. Major factors driving the market growth at significant CAGR are increasing adoption of 3D cell culture over, restrictions over animal testing and increased use of 3D cell culture in personalized medicine.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847
Browse in-depth TOC on “3D Cell Culture Market”
205 – Tables
39 – Figures
244 – Pages
3D Cell Culture Market Scope:
Report Coverage | Details |
Market Revenue in 2023 | $1.3 billion |
Estimated Value by 2028 | $2.5 billion |
Growth Rate | Poised to grow at a CAGR of 14.6% |
Market Size Available for | 2021-2028 |
Forecast Period | 2023–2028 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, Application, End user and Region |
Geographies Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Report Highlights | Updated financial information / product portfolio of players |
Key Market Opportunities | Emergence of microfluidics-based 3D cell culture |
Key Market Drivers | High focus on developing alternatives to animal testing |
Scaffold-based 3D cell culture accounted for the largest share of the product segment in the 3D cell culture market in 2022.
Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2022. The advantages of scaffolds in 3D cell cultures, such as structural rigidity, the availability of attachment points, and support, have greatly driven the preference for the segment and ensured its large share in the market.
The cancer & stem cell segment research segment accounted for the largest share of the application segment in the 3D cell culture market in 2022.
Based on application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share of the market in 2022. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment..
Asia Pacific is likely to grow at the highest growth rate during the forecast period.
Based on region, the 3D cell culture market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The increasing incidence of cancer and a well-established pharmaceutical & biotechnology industry are key factors supporting the growth of the North American 3D cell culture market. The Asia Pacific market is projected to grow at the highest CAGR of 16.0% during the forecast period. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847
3D Cell Culture Market Dynamics:
Drivers:
- High focus on developing alternatives to animal testing
- Greater adoption of personalized medicine globally for multiple diseases
- Increased government support and funding for 3D cell culture
- Increased industry-academia collaboration on 3D cell culture and research
Restraints:
- High costs of implementing 3D cell culture technologies
- Lack of widely accepted or single standardization in 3D cell culture
Opportunities:
- Emergence of microfluidics-based 3D cell culture
- High growth opportunities and booming biopharmaceutical sector in emerging economies
Challenges:
- Lack of consistency in 3D cell culture products
- High dependence on plastic waste disposals and consumables
Key Market Players:
The 3D cell culture market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific. Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) are some of the leading players in this market.
Recent Developments:
- In October 2022, Corning launched the Elplasia 12K flask featuring a unique microcavity geometry that enables easy spheroid formation, culture, treatment, assessment, and harvest, with approximately 12,000 spheroids of uniform size and shape per flask, generating 125 times more yield than conventional 96-well spheroid plates.
- In March 2021, Thermo Fisher Scientific launched a plasma-like medium, a cell culture medium that mimics the metabolic profile of human plasma, designed to provide researchers with a realistic view of cell growth within the human body.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=191072847
3D cell culture Market – Report Highlights:
- Key conferences, and events 2022-2023, key stakeholders & buying criteria, pipeline analysis and trends/ disruptions impacting customer business are added in the market overview chapter.
- The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This would help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.
- Impact of the recession has also been added in the new addition of the report.
- Recent developments are helpful to understand market trends and growth strategies adopted by players in the market.
- The hydrogel/ ECM segment is further subsegmented into synthetic and natural hydrogels.
- Tracking product portfolios of prominent market players helps to analyze the major products in the 3D cell culture market. The new edition of the report provides an updated service portfolio of the companies profiled in the report.
- Market evaluation framework, market share analysis, and competitive leadership mapping have been added in the competitive landscape chapter of the report.
- The competitive leadership mapping has been updated considering recent developments in the company evaluation matrix.
Related Reports:
Cell-based Assays Market – Global Forecasts to 2028
High Throughput Screening Market – Global Forecasts to 2028
Cell Culture Market – Global Forecasts to 2028
3D Bioprinting Market – Global Forecasts to 2027
In Vitro Toxicology Testing Market – Global Forecasts to 2027
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/3d-cell-culture-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/3d-cell-culture.asp